Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Thalidomide × CNS × Clear all

Phase

Status

Completed 18 Unknown 1 Terminated 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 3 Plasma cell 1 Lymphoid 1 Gastrointestinal 1 CNS 1

Conditions

Recurrence 1 Medulloblastoma 1 Ependymoma 1

Interventions

Temozolomide 67 Magnetic Resonance Spectroscopy 61 Radiotherapy 41 Specimen Handling 39 Radiosurgery 31 Bevacizumab 23 Cyclophosphamide 22 pembrolizumab 20 Radiation 18 Blood Specimen Collection 14 fludarabine 12 Lomustine 12 Irinotecan 12 Pemetrexed 11 Nivolumab 11 Etoposide 10 Carboplatin 10 Biopsy 10 Vincristine 9 Surgical Procedures, Operative 9 trametinib 8 lutetium Lu 177 dotatate 8 Ipilimumab 8 Fluorodeoxyglucose F18 8 naxitamab 7 fluciclovine F-18 7 Proton Therapy 7 Everolimus 7 Drug Therapy 7 olaparib 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01356290 2026-02-23

MEMMAT

Medical University of Vienna

Phase 2 Recruiting

Ependymoma, Medulloblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡